United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2026 financial results ...
(Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule ...
Company to host conference call and webcast on November 5, 2026, at 8:00 a.m. ET (9:00 p.m. HKT) SHANGHAI & CAMBRIDGE, Mass.- ...
Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced the acceptance of 12 ...
Robin Swartz, Voyager’s Chief Business and Operating Officer, appointed President, effective immediately; expected to succeed ...
ProBio Inc., a global contract research, development and manufacturing organization (CRDMO), today announced the successful ...
Two New Patient Registries to Be Implemented on NORD's IAMRARE® Platform with support from the Critical Path Institute.
Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, ...
New research led by the University of Colorado Anschutz is offering hope to people living with stiff person syndrome (SPS), ...
Agencies aligned on trial design, endpoints and safety database; FDA agreed NDA-enabling studies can run in parallel with ...
Patient-derived liver and intestinal disease models are designed to help drug developers test whether a candidate reduces ...
Hibsago’s approval—a functional cure for certain patients with a hepatitis B infection—further validates Ionis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results